Cancer genetics fundamentals

Cancer Nursing

Volumn 24, Issue 6, 2001, Pages 446-461

  Peters, June ^a,b   Loud, Jennifer ^a   Dimond, Eileen ^a   Jenkins, Jeanne ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b National Naval Medical Center ^*  (United States)

Author keywords

Angiogenesis; Apoptosis; Cancer genetics; Carcinogenesis; Cell cycle; Genetic counseling; Neoplasm

Indexed keywords

ANGIOGENESIS; CANCER; CANCER GENETICS; CANCER INVASION; CARCINOGENESIS; CELL DEATH; GROWTH INHIBITION; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW;

EID: 0035180613     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200112000-00005     Document Type: Review

References (115)

1. The genetic basis of cancer
2. Mechanism-based cancer prevention approaches: Targets, examples and the use of transgenic mice
3. The molecular biology of cancer
4. The hallmarks of cancer
5. How many mutations are required for tumorigenesis? Implications from human cancer data
6. A genetic model for colorectal tumorigenesis
7. Lessons from hereditary colorectal cancer
8. Introduction to cancer genetics
9. Genetic pathways in colorectal and other cancers
10. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
11. Cancer genetics
12. Genetic testing for cancer susceptibility
13. Genetics of smoking-related cancer and mutagen sensitivity
14. Oncogenes and tumor suppressor genes
15. Oncogenes
16. Oncogenes
17. RET proto-oncogene in the development of human cancer
18. Multiple endocrine neoplasia type 2
19. Mutation and cancer: Statistical study of retinoblastoma
20. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
21. Genetic sequences that predispose to retinoblastoma and osteosarcoma
22. Tumor suppressor genes
23. Cell cycle control: An overview
24. Cell cycle and cancer
25. Cancer cell cycles
26. Functions of the retinoblastoma protein
27. ECM and cell surface proteolysis: Regulating cellular ecology
28. Apoptosis and cancer
29. Apoptosis in development
30. Mitochondria and apoptosis
31. Caspases: Enemies within
32. Oncogenesis
33. Mortality and immortality at the cellular leve. A review
34. A survey of telomerase activity in human cancer
35. Telomerase and the maintenance of chromosome ends
36. Telomere elongation in immortal human cells without detectable telomerase activity
37. Telomerase activity in human cancer
38. How tumors become angiogenic
39. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
40. Src related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells
41. Tumor angiogenesis
42. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
43. Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, cadherins, immunoglobulin-cell adhesion molecules and selectins
44. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene
45. Mutator phenotype may be required for multistage carcinogenesis
46. Genetic instabilities in human cancers
47. Tumor genome instability
48. JNCI News when theories collide: Experts develop different models for carcinogenesis
49. Chromosome aberrations and cancer
50. Chromosome alterations in human solid tumors
51. Applications of fluorescent in situ hybridization (FISH) to genetic analysis of human tumors
52. Comparative genomic hybridization: A rapid new method for detecting and mapping DNA amplification in tumors
53. Linking chromosomal clues
54. Multicolor spectral karyotyping of human chromosomes
55. Genes altered by chromosomal translocations in leukemias and lymphomas
56. Oncology applications of cancer genetics
57. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
58. Gene-expression profiles in hereditary breast cancer
59. Ataxia-telangiectasia
60. Nucleotide excision repair syndromes: Xeroderma Pigmentosum, Cockayne Syndrome, and Trichothiodystrophy
61. Bloom syndrome
62. Fanconi anemia
63. The bone marrow failure syndromes
64. Microsatellite instability: Marker of a mutator phenotype in cancer
65. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction
66. Microsatellite instability in cancer of the proximal colon
67. Genetic mapping of a locus predisposing to human colorectal cancer
68. Hereditary nonpolyposis colorectal cancer (HNPCC)
69. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
70. Destabilization of tracts of sample repetitive DNA in yeast by mutations affecting DNA mismatch repair
71. Mutations of a mut S homolog in hereditary nonpolyposis colorectal cancer
72. Genetic mapping of a second locus predisposing to hereditary nonpolyposis colon cancer
73. Loss of the wild-type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer
74. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer
75. Mutation of a mutL homolog in hereditary colon cancer
76. Identification of mismatch repair genes and their role in the development of cancer
77. Mismatch repair: Mechanisms and relationship to cancer susceptibility
78. Mutations in two PMS homologues in hereditary nonpolyposis colon cancer
79. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6
80. Germloine mutation of MSH 6 as the cause of hereditary nonpolyposis colorectal cancer
81. Mismatch repair, genetic stability and cancer
82. Molecular genetics of hereditary nonpolyposis colorectal cancer
83. Deficient DNA mismatch repair: A common etiologic factor for colon cancer
84. The Lynch syndrome: Melding natural history and molecular genetics to genetic counseling and cancer control
85. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
86. Gene amplification in human cancers: Biological and clinical significance
87. Genomic imprinting and gene activation in cancer
88. Genomic imprinting and cancer
89. DNA viruses
90. RNA viruses
91. Etiology of cancer: Viruses
92. Molecular profiling of human cancer
93. Identification of gene expression profiles that predict the aggressive behavior of breast cancer
94. A learning algorithm diagnoses prostate and ovarian cancer from human serum based on multiparametric proteomic patterns
95. Integration of genomic and proteomic analyses of a systematically perturbed metabolic pathway
96. Proliferation, cell cycle and apoptosis in cancer
97. The microenvironment of the tumour-host interface